Table 1 Summary of clinical characteristics of patients with AESD in GWAS.

From: GWAS identifies candidate susceptibility loci and microRNA biomarkers for acute encephalopathy with biphasic seizures and late reduced diffusion

Clinical characteristics

Number of the patients

N = 254

%

Sex

 Male

121

47.6

 Female

133

52.4

Age (months)

 < 12

51

20

 12–24

110

43.3

 > 24

93

36.6

Early seizuresa

 Status epilepticus (> = 15 min)

212

83.5

 Short seizure (< 15 min)

40

15.7

 Unknown

2

0.8

Late seizuresb

 Yes

199

78.3

 No

46

18.1

 Unknown

9

3.5

MRI findingsc

 Yes

242

95.3

 No

12

4.7

Outcome

 Full recovery

42

16.5

 Neurological sequelaed

170

66.9

 Death

0

0

 Unknown

42

16.5

  1. aEarly seizures: generalized convulsion in the early phase of AESD.
  2. bLate seizures: cluster of focal seizures in the late phase.
  3. cMRI findings: characteristic lesions in the cerebral subcortical white matter detected by cranial MRI.
  4. dNeurological sequelae: intellectual and/or motor disability.
Back to article page